Patients in Dawson Creek could soon see more affordable options for a widely used diabetes and weight-loss medication, as new generic versions of Ozempic begin arriving in Canada.
Health Canada approved two generic forms of semaglutide, the active ingredient in Ozempic earlier this month, with products from Dr. Reddy’s and Canadian-based Apotex now entering the supply chain.
Apotex says it began shipping its version this week, while Dr. Reddy’s product is expected to become more widely available across the country in the coming days.
Locally, pharmacists in Dawson Creek say it won’t be long before the medications hit shelves.
Kayle Christensen, a pharmacist with Nordlys pharmacy, says shipments are expected before the end of the week.
“With the new generic versions of Ozempic, the price will come down by less than half. That will make it much more accessible for those who need it,” said Christensen.
Semaglutide has surged in popularity in recent years, primarily for managing diabetes but also for off-label weight loss use, driving high demand and high costs.
Brand-name Ozempic can cost hundreds of dollars per month, but generic versions are typically priced significantly lower. Under national pricing guidelines, when multiple generics enter the market, prices are often at least 50 per cent less than the brand-name drug.
Industry groups say availability may vary at first, as the medications move through distributors before reaching individual pharmacies across the country.
Experts say patients paying out of pocket are likely to see access first, while provincial and private insurance coverage may take more time to catch up.
Health Canada is continuing to review additional applications for generic semaglutide products, raising the possibility of even more options — and further price reductions — in the months ahead.
With files from the Canadian Press